Sunstar recalls gingivitis drug due to potential bacterial contamination

Medical supply company Sunstar Americas is recalling its gingivitis oral rinse, proex chlorhexidine gluconate, after finding it may be contaminated with bacteria. 

Using the recalled product may cause oral or systemic infections requiring antibacterial therapy, the company said. The drug may contain Burkholderia lata, which in at-risk populations may cause life-threatening infections such as pneumonia and bacteremia. No adverse events have been reported, Sunstar said. 

The prescription oral rinse is designed to treat gingivitis and has been distributed nationwide to dental offices, dental distributors, pharmaceutical wholesalers, dental schools and pharmacies. 

Sunstar said it is notifying its distributors and customers by U.S. Postal Service priority mail and arranging for all affected products to be returned. Patients, pharmacies and healthcare facilities should stop using and dispensing the drug immediately, the company said. 

Read the full news release here.

More articles on pharmacy:
FDA is letting COVID-19 vaccine makers skip inspection before emergency authorization
Vertex urged to address 'fatal inequality' in access to its cystic fibrosis drug
CVS to add rapid COVID-19 testing at 1,000 pharmacies

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers